The Data Behind Social Determinants of Health Research

  • This page as PDF


New Avalere study entitled “Using Aggregate Data to Proxy Individual-Level Socioeconomic Characteristics in Research on Medication Adherence: 9-Digit ZIP Code vs. Census Block Group” selected for the AMCP Foundation Best Poster Award at AMCP Nexus 2018.
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.

Addressing social determinants of health (SDH) is viewed as fundamental to improving care delivery and lowering healthcare costs in the US. However, information on SDH is difficult to obtain and existing data sources are incomplete. Because of these limitations, researchers commonly rely on readily available aggregate proxy data (e.g., census tracts and block groups) to make inferences about individual-level SDH characteristics within a geographic area.

Avalere’s study, presented at AMCP Nexus 2018 on October 22, 2018, compares two aggregate proxy data sources—9-digit ZIP code and census block group—on their ability to predict health outcomes, specifically medication adherence, based on SDH characteristics. The results indicate that aggregating data across a smaller group of individuals (e.g., the 9-digit ZIP code) can provide a more precise measurement of sociodemographic differences, and thus would be more useful to researchers in predicting patient outcomes, risk, and costs. It also underscores the importance of using granular enough data in risk adjusting quality measures to ensure a level playing field for providers so that rewards or penalties are fairly assessed and based on true differences in performance.

To learn more about this study and Avalere’s research capabilities, connect with us.

Webinar | A Closer Look at Patient Support Avalere experts explored how potential implications of the Inflation Reduction Act (IRA)’s out-of-pocket cap, in addition to other key regulatory and policy activities shaping benefit design and patient cost-share (e.g., EHB), could impact patient commercial and foundation assistance. Learn More
Watch Now
From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about Health Equity
Please enter your email address to be notified when new Health Equity insights are published.

Back To Top